These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28820895)

  • 1. Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis.
    Jamal F; Shivam P; Kumari S; Singh MK; Sardar AH; Pushpanjali ; Murugesan S; Narayan S; Gupta AK; Pandey K; Das VNR; Ali V; Bimal S; Das P; Singh SK
    PLoS One; 2017; 12(8):e0182474. PubMed ID: 28820895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of B-cell Epitope of Leishmania donovani and its application in diagnosis of visceral leishmaniasis.
    Jamal F; Dikhit MR; Singh MK; Shivam P; Kumari S; Pushpanjali S; Dubey AK; Kumar P; Narayan S; Gupta AK; Pandey K; Das VNR; Bimal S; Das P; Singh SK
    J Biomol Struct Dyn; 2017 Dec; 35(16):3569-3580. PubMed ID: 27892844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoblotting identifies an antigen recognized by anti gp63 in the immune complexes of Indian kala-azar patient sera.
    Sanyal T; Ghosh DK; Sarkar D
    Mol Cell Biochem; 1994 Jan; 130(1):11-7. PubMed ID: 8190117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoproteins in circulating immune complexes are biomarkers of patients with Indian PKDL: A study from endemic districts of West Bengal, India.
    Jaiswal P; Datta S; Sardar B; Chaudhuri SJ; Maji D; Ghosh M; Saha B; Mukhopadhyay S
    PLoS One; 2018; 13(2):e0192302. PubMed ID: 29420575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Characterization of a Novel, 37-Kilodalton Leishmania donovani antigen for diagnosis of Indian visceral leishmaniasis.
    Kumar S; Kumar D; Chakravarty J; Sundar S
    Clin Vaccine Immunol; 2011 May; 18(5):772-5. PubMed ID: 21411602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune complex antigens as a tool in serodiagnosis of kala-azar.
    Chakraborti T; Sarkar D; Ghosh DK
    Mol Cell Biochem; 2003 Nov; 253(1-2):191-8. PubMed ID: 14619969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of major antigens of Leishmania donovani using kala azar sera.
    Arora SK; Sehgal S
    Med Microbiol Immunol; 1989; 178(2):81-8. PubMed ID: 2733636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of leishmania antigen in kala azar patients using monoclonal antibodies.
    Sinha R; Arora SK; Datta U; Sehgal S
    Microbiol Immunol; 1992; 36(4):391-400. PubMed ID: 1406366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A diagnostic ELISA for visceral leishmaniasis, based on antigen from media conditioned by Leishmania donovani promastigotes.
    Martin SK; Thuita-Harun L; Adoyo-Adoyo M; Wasunna KM
    Ann Trop Med Parasitol; 1998 Jul; 92(5):571-7. PubMed ID: 9797830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antigen specific circulating immune complexes in Indian kala-azar.
    Srivastava L
    Ann Trop Med Parasitol; 1989 Oct; 83(5):521-5. PubMed ID: 2482707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a 200-kDa amastigote-specific antigen of L. donovani by enzyme-linked immunosorbent assay (ELISA) for the diagnosis of visceral leishmaniasis.
    Kaul P; Malla N; Kaur S; Mahajan RC; Ganguly NK
    Trans R Soc Trop Med Hyg; 2000; 94(2):173-5. PubMed ID: 10897360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel 12.6-kDa protein of Leishmania donovani for the diagnosis of Indian visceral leishmaniasis.
    Kumar D; Kumar S; Chakravarty J; Sundar S
    Vector Borne Zoonotic Dis; 2011 Oct; 11(10):1359-64. PubMed ID: 21923256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
    J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a circulating antigen involved in immune complexes in visceral leishmaniasis patients.
    Mary C; Ange G; Dunan S; Lamouroux D; Quilici M
    Am J Trop Med Hyg; 1993 Oct; 49(4):492-501. PubMed ID: 8214280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PEG-ELISA for the detection of Leishmania donovani antigen in circulating immune complexes.
    Azazy AA; Devaney E; Chance ML
    Trans R Soc Trop Med Hyg; 1994; 88(1):62-6. PubMed ID: 7512290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis.
    Ghedin E; Zhang WW; Charest H; Sundar S; Kenney RT; Matlashewski G
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):530-5. PubMed ID: 9302200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of purified parasite proteins from Leishmania donovani for the rapid serodiagnosis of visceral leishmaniasis.
    Jaffe CL; Zalis M
    J Infect Dis; 1988 Jun; 157(6):1212-20. PubMed ID: 3373022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania infantum recombinant kinesin degenerated derived repeat (rKDDR): A novel potential antigen for serodiagnosis of visceral leishmaniasis.
    Dhom-Lemos L; Viana AG; Cunha JLR; Cardoso MS; Mendes TAO; Pinheiro GRG; Siqueira WF; Lobo FP; Teles LF; Bueno LL; Guimarães-Carvalho SF; Bartholomeu DC; Fujiwara RT
    PLoS One; 2019; 14(1):e0211719. PubMed ID: 30703138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
    Marlais T; Bhattacharyya T; Singh OP; Mertens P; Gilleman Q; Thunissen C; Hinckel BCB; Pearson C; Gardner BL; Airs S; de la Roche M; Hayes K; Hafezi H; Falconar AK; Eisa O; Saad A; Khanal B; Bhattarai NR; Rijal S; Boelaert M; El-Safi S; Sundar S; Miles MA
    Front Cell Infect Microbiol; 2018; 8():427. PubMed ID: 30619774
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.
    Singh S; Kumari V; Singh N
    Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.